Optimising Therapy In Anti-neutrophil Cytoplasmic Antibody (ANCA) Associated Vasculitis
Funder
National Health and Medical Research Council
Funding Amount
$124,676.00
Summary
ANCA vasculitis is a rare autoimmune condition causing inflammation in small blood vessels, that can lead to organ failure and death. This research will help identify the best treatment approach for different subgroups of patients and the best timing of certain treatments. We will also explore patient symptoms and experience of this condition, and how this relates to disease activity, damage and medication effects.
Targeting Autophagy As A Means Of Control Of Cytokine Production In SLE
Funder
National Health and Medical Research Council
Funding Amount
$616,518.00
Summary
Systemic lupus erythematosus (SLE, or lupus) is a common immune disease that causes organ damage and loss of life, chiefly affecting young women. There is no cure for SLE. We have discovered that a natural process called 'autophagy' could be a way to limit inflammation during SLE. In this project we will discover whether this could lead to a new way to treat this disease.
Optimising Primary Care Management Of Knee Osteoarthritis: The PARTNER Project.
Funder
National Health and Medical Research Council
Funding Amount
$1,155,444.00
Summary
Our overall aim is to implement a cost-effective, sustainable, evidence-based model of co-ordinated primary care targeting both the general practitioner and the patient that improves management and outcomes for overweight/obese people with knee osteoarthritis (OA) and reduces health care costs.
This fellowship will allow the applicant to continue to study the major musculoskeletal diseases in Australia (osteoarthritis, osteoporosis and rheumatoid arthritis) using a combination of observational and interventional studies.
New Approaches To The Prevention And Treatment Of Musculoskeletal Disease
Funder
National Health and Medical Research Council
Funding Amount
$466,492.00
Summary
In Australia, musculoskeletal conditions like osteoarthritis and back pain are responsible for much pain and disability. Although until recently these were considered to be purely due to wear and tear, Associate Professor Wluka, a rheumatologist, has shown that these are not simply due to overuse and loading but metabolic factors also play a role. This award will enable the role of these factors to be examined and new therapies tested in clinical trials, providing evidence to improve the managem ....In Australia, musculoskeletal conditions like osteoarthritis and back pain are responsible for much pain and disability. Although until recently these were considered to be purely due to wear and tear, Associate Professor Wluka, a rheumatologist, has shown that these are not simply due to overuse and loading but metabolic factors also play a role. This award will enable the role of these factors to be examined and new therapies tested in clinical trials, providing evidence to improve the management of these conditions.Read moreRead less
Does Low Dose Amitriptyline Reduce Pain In Knee Osteoarthritis? A Double Blind, Randomised, Pragmatic, Placebo Controlled Clinical Trial Of Amitriptyline In Addition To Usual Care
Funder
National Health and Medical Research Council
Funding Amount
$413,704.00
Summary
Pain is the main problem for people with osteoarthritis, a common form of arthritis. This pain is not controlled well. Pain comes from structural changes in the joint. However, after time, some people develop pain due to changes in the nervous system, called pain sensitisation. This is not affected by usual treatments. Amitriptyline is used to treat pain sensitisation. This study is a randomised trial to see whether amitriptyline, relieves pain in people with knee osteoarthritis over 3 months.
Footwear For Self-managing Knee Osteoarthritis Symptoms: The Footstep Trial
Funder
National Health and Medical Research Council
Funding Amount
$590,532.00
Summary
Self-management of symptoms is an important part of treatment for people with knee osteoarthritis. Footwear influences forces across the knee joint and it is unclear which types of shoes are best to minimise arthritis symptoms. This study will compare the effects of flat flexible shoes to stable supportive shoe styles on pain and physical function over 6 months in people with painful knee osteoarthritis.
Knee osteoarthritis (OA) affects about 30% of Australians over the age of 65, but also at younger ages. It causes joint pain and stiffness, especially on exercise. The cause is unknown but it results in loss of joint cartilage. There are few treatments available to stop the progression, which can finally result in need for an artificial joint. Most treatments such as paracetamol and non-steroid anti-inflammatory drugs (NSAIDs) reduce pain but have no effect on cartilage. NSAIDs can have serious ....Knee osteoarthritis (OA) affects about 30% of Australians over the age of 65, but also at younger ages. It causes joint pain and stiffness, especially on exercise. The cause is unknown but it results in loss of joint cartilage. There are few treatments available to stop the progression, which can finally result in need for an artificial joint. Most treatments such as paracetamol and non-steroid anti-inflammatory drugs (NSAIDs) reduce pain but have no effect on cartilage. NSAIDs can have serious side effects such as stomach ulcers and increased cardiovascular events (such as heart attacks). Fish oil has possible benefits in OA as it decreases pain and inflammation in rheumatoid arthritis (RA, another type of arthritis with joint inflammation and swelling), less use of NSAID in patients with RA, and in laboratory experiments may reduce cartilage breakdown in OA. It is likely that fish oil will have few side effects and decrease blood cholesterol. Many people with OA are already taking fish oil, however, there is no studies to know if it is effective in OA. The aim of this proposal is to study the effect of fish oil on pain and progression of knee OA, by doing a randomised clinical trial. Participants with knee OA will be given either high dose fish oil or similar oil with low levels of fish oil. The study will run for 2 years and during that time, we will measure pain and blood levels of fatty acids (part of the fish oil) and cholesterol. At the beginning and end of the study, magnetic resonance imaging (MRI) of the knee, a knee xray, and bone density testing will be done. The outcomes of the study will be to determine if fish oil affects pain and function (measured by questionnaires) and progression of OA (measured by cartilage changes on MRI). If fish oil is shown to reduce pain and disability and cartilage loss in OA, it will provide Australians with OA an alternative treatment that is low in side effects with positive effects on cardiovascular disease.Read moreRead less
Improving Outcomes In Systemic Autoimmune Disease: A Collaborative And Interdisciplinary Program Of Research
Funder
National Health and Medical Research Council
Funding Amount
$425,048.00
Summary
The multi-organ autoimmune diseases ‘scleroderma’ and ‘lupus’ have a profound negative impact on quality of life and life expectancy. The overall goal of my research is to improve patient outcomes in these two diseases. My collaborative and interdisciplinary research program entails quantifying disease burden, identifying patient subsets, optimising screening for complications, developing outcome measures for use in practice and research, and trialing new therapies.
A Randomised Trial Of Krill Oil For Osteoarthritis Of The Knee
Funder
National Health and Medical Research Council
Funding Amount
$751,491.00
Summary
This study trials krill oil vs placebo, for painful knee osteoarthritis in people with joint swelling on MRI scans, to assess if krill oil reduces knee pain and knee swelling over 24 weeks. If krill oil can delay loss of knee cartilage through effects on cartilage and bone, this this could lead to a delay in the time to knee replacement surgery and improvements in quality of life for those suffering from OA.